Is coronary artery disease complexity valuable in the prediction of contrast induced nephropathy besides mehran risk score, in patients with st elevation myocardial infarction treated with primary percutaneous coronary intervention?

Heart Lung and Circulation

Volumn 22, Issue 10, 2013, Pages 836-843

  Aykan, Ahmet Çaǧri ^a   Gul, Ilker ^a   Gökdeniz, Tayyar ^a   Kalaycioǧlu, Ezgi ^a   Turan, Turhan ^a   Boyaci, Faruk ^a   Erkan, Hakan ^a   Hatem, Engin ^a   Aykan, Duygun Altintaş ^b   Çelik, Şükrü ^a  

^a Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Contrast; Coronary; Mehran score; Myocardial infarction; Nephropathy; SYNTAX score

Indexed keywords

HIGH DENSITY LIPOPROTEIN; CONTRAST MEDIUM;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEART INFARCTION LOCALIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; INCIDENCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEHRAN SCORE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT IDENTIFICATION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNTAX SCORE; CHEMICALLY INDUCED; CLINICAL TRIAL; KIDNEY DISEASE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; RADIOGRAPHY; RISK FACTOR;

AGED; CONTRAST MEDIA; CORONARY ARTERY DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTORS;

EID: 84885310300     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.03.085     Document Type: Article

References (20)

1. Thomsen H.S., Morcos S.K. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines. Br J Radiol. 2003, 76(908):513-518.
2. Marenzi G., Lauri G., Assanelli E., Campodonico J., De Metrio M., Marana I., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004, 44(9):1780-1785.
3. Senoo T., Motohiro M., Kamihata H., Yamamoto S., Isono T., Manabe K., et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 2010, 105(5):624-628.
4. Wickenbrock I., Perings C., Maagh P., Quack I., van Bracht M., Prull M.W., et al. Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol 2009, 98(12):765-772.
5. Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004, 44(7):1393-1399.
6. Sianos G., Morel M.A., Kappetein A.P., Morice M.C., Colombo A., Dawkins K., et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005, 1(2):219-227.
7. Capodanno D., Di Salvo M.E., Cincotta G., Miano M., Tamburino C., Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2009, 2(4):302-308.
8. Coskun U., Orta Kilickesmez K., Abaci O., Kocas C., Bostan C., Yildiz A., et al. The relationship between chronic kidney disease and SYNTAX score. Angiology 2011, 62(6):504-508.
9. O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., de Lemos J.A., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 61(4):78-140.
10. Harjai K.J., Raizada A., Shenoy C., Sattur S., Orshaw P., Yaeger K., et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008, 101(6):812-819.
11. McCullough P.A. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008, 51(15):1419-1428.
12. Stacul F., van der Molen A.J., Reimer P., Webb J.A., Thomsen H.S., Morcos S.K., et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee Guidelines. Eur Radiol 2011, 21(12):2527-2541.
13. Marenzi G., Assanelli E., Marana I., Lauri G., Campodonico J., Grazi M., et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006, 354(26):2773-2782.
14. Marenzi G., Assanelli E., Campodonico J., Lauri G., Marana I., De Metrio M., et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009, 150(3):170-177.
15. Zhao J.L., Yang Y.J., Zhang Y.H., You S.J., Wu Y.J., Gao R.L. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty. Int J Cardiol 2008, 126(3):435-436.
16. Wi J., Ko Y.G., Shin D.H., Kim J.S., Kim B.K., Choi D., et al. Prediction of contrast-induced nephropathy with persistent renal dysfunction and adverse long-term outcomes in patients with acute myocardial infarction using the Mehran risk score. Clin Cardiol. 2013, 36(1):46-53.
17. Lindsay J., Canos D.A., Apple S., Pinnow E.E., Aggrey G.K., Pichard A.D. Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine. Am J Cardiol 2004, 94(6):786-789.
18. Nikolsky E., Mehran R., Lasic Z., Mintz G.S., Lansky A.J., Na Y., et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005, 67(2):706-713.
19. Iakovou I., Dangas G., Mehran R., Lansky A.J., Ashby D.T., Fahy M., et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003, 15(1):18-22.
20. Elbasan Z., Sahin D.Y., Gür M., Kuloglu O., Kivrak A., Içen Y.K., et al. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology 2012, Oct 29, epub.